14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $4.71 $5.41 Wednesday, 1st May 2024 AUPH stock ended at $5.20. This is 2.16% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 4.64% from a day low at $5.07 to a day high of $5.31.
90 days $4.71 $8.49
52 weeks $4.71 $12.42

Historical Aurinia Pharmaceuticals Inc prices

Date Open High Low Close Volume
Nov 03, 2021 $30.22 $33.97 $29.65 $30.39 8 302 900
Nov 02, 2021 $32.32 $33.00 $31.50 $32.00 4 494 342
Nov 01, 2021 $32.00 $33.47 $31.30 $32.63 5 110 181
Oct 29, 2021 $30.34 $33.10 $29.80 $33.08 7 413 627
Oct 28, 2021 $28.98 $32.71 $28.75 $29.96 9 658 285
Oct 27, 2021 $29.08 $30.50 $28.50 $29.92 4 569 274
Oct 26, 2021 $29.80 $30.75 $29.00 $30.35 8 112 887
Oct 25, 2021 $30.14 $30.95 $29.25 $29.84 15 912 145
Oct 22, 2021 $21.80 $28.00 $21.66 $28.00 6 110 528
Oct 21, 2021 $20.69 $22.39 $20.69 $22.09 3 750 366
Oct 20, 2021 $20.01 $20.96 $19.78 $20.65 3 946 794
Oct 19, 2021 $19.81 $20.69 $19.81 $19.93 1 614 882
Oct 18, 2021 $20.54 $20.67 $19.61 $19.70 2 121 205
Oct 15, 2021 $21.07 $21.24 $20.52 $20.57 1 552 174
Oct 14, 2021 $21.25 $21.53 $20.80 $21.04 1 398 015
Oct 13, 2021 $20.81 $21.56 $20.66 $21.25 1 966 607
Oct 12, 2021 $20.58 $21.75 $20.36 $20.69 3 240 843
Oct 11, 2021 $19.26 $20.98 $18.33 $20.48 4 850 134
Oct 08, 2021 $19.68 $20.42 $19.25 $19.33 1 806 384
Oct 07, 2021 $19.20 $20.30 $18.87 $19.84 2 631 387
Oct 06, 2021 $20.90 $21.30 $17.65 $18.85 7 740 192
Oct 05, 2021 $21.26 $22.00 $21.00 $21.28 2 133 048
Oct 04, 2021 $21.75 $22.64 $20.95 $21.09 2 886 718
Oct 01, 2021 $22.09 $22.29 $20.81 $21.81 3 534 905
Sep 30, 2021 $22.99 $23.17 $21.89 $22.13 2 550 715
Click to get the best stock tips daily for free!

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.... AUPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT